ARMP — Armata Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $143.89m
- $403.45m
- $4.90m
Brief: Armata Pharmaceuticals Announces The Addition Of Robin C. Kramer To Its Board Of Directors
Brief: Armata Pharmaceuticals Reports Q3 2020 Results
Brief: Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS As Vice President Of Clinical Development
U.S. STOCKS ON THE MOVE-Peloton, Mondelez, Vertex Pharma, Cars.com
U.S. STOCKS ON THE MOVE-Charles Schwab, Walgreens, Fastly, United Airlines
U.S. STOCKS ON THE MOVE-Walgreen, Vertex Pharma, United Airlines, Lemonade
Armata Pharma: Up on FDA nod for human trial of bacterial infections treatment
Brief: Armata Pharmaceuticals Announces Clearance Of Investigational New Drug Application To Initiate Phase 1B/2A Clinical Trial Of Lead Candidate AP-Pa02 In Pseudomonas Aeruginosa Infections
Brief: Armata Pharmaceuticals Announces Second Quarter 2020 Results And Provides General Corporate Update
Armata Pharmaceuticals: Gains on U.S. defense department funding for drug development
Brief: Armata Pharmaceuticals Announces $15 Mln Award From The U.S. Department Of Defense
Brief: Armata Pharma Reports Quarterly Loss Per Share Of $0.49
Brief: Armata Pharmaceuticals Files Prospectus Relates To Disposition Of Up To 8.7 Mln Common Shares, 8.7 Mln Common Shares Issuable Upon Exercise Of Warrants
Brief: Armata Pharmaceuticals Files For Mixed Shelf Of Up To $100 Mln
Brief: Armata Pharmaceuticals Says On March 13, Entered Into An Award Agreement With Cystic Fibrosis Foundation - SEC Filing
Brief: Armata Pharma Qtrly Loss Per Share $0.48
Armata Pharma rises after $5 mln award to support drug development
U.S. STOCKS ON THE MOVE-3M, Xerox, Acceleron, BorgWarner, Delphi
Armata Pharma: Soars to 1-yr high on $25 mln stocks and warrants deal